Offer - Urjas Oil for just ₹ 1 X
Olmin 40 LN Tablet is a prescription drug, available for use as Tablet. The alternative uses of Olmin 40 LN Tablet have also been explained below.
The correct dosage of Olmin 40 LN Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The side effects typically associated with Olmin 40 LN Tablet include Upper respiratory tract infection. While these are the most often observed Olmin 40 LN Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Olmin 40 LN Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Olmin 40 LN Tablet has a Unknown effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Olmin 40 LN Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) must refrain from the use of Olmin 40 LN Tablet since this can cause severe adverse effects. Other contraindications of Olmin 40 LN Tablet have been discussed in the sections ahead.
Additionally, Olmin 40 LN Tablet may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Olmin 40 LN Tablet is considered safe while driving, and is addictive.
Olmin 40 LN Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmin 40 LN Tablet safe for pregnant women?
No research has been done to ascertain the safety of Olmin LN in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Olmin 40 LN Tablet safe during breastfeeding?
There is no research available on the side effects of Olmin LN in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Olmin 40 LN Tablet on the Kidneys?
Olmin LN has very mild side effects on the kidneys.
What is the effect of Olmin 40 LN Tablet on the Liver?
Olmin LN has very mild side effects on the liver.
What is the effect of Olmin 40 LN Tablet on the Heart?
There may be an adverse effect on the heart after taking Olmin LN. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Olmin 40 LN Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmin 40 LN Tablet unless your doctor advises you to do so -
Is this Olmin 40 LN Tablet habit forming or addictive?
Forming a habit of Olmin 40 LN Tablet has not been reported.
Interaction between Food and Olmin 40 LN Tablet
Taking Olmin 40 LN Tablet with food does not cause any problems.
Interaction between Alcohol and Olmin 40 LN Tablet
It is difficult to say anything about the effect of Olmin 40 LN Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173